Human Trial Suggests CRISPR Could Be a Viable Cancer Treatment

By Kristin Houser – Re-Blogged From Futurism

This could be great news for experimental cancer treatments.

Scientists from the University of Pennsylvania just published the results of the first U.S. trial of CRISPR-edited cells in cancer patients — and they’re very encouraging.

In April 2019, UPenn confirmed that a team of its researchers had officially begun testing CRISPR-edited cells in humans.

For that trial, the scientists had removed immune cells from three patients with advanced, treatment-resistant cancers. They then used CRISPR-Cas9 to edit the cells in order to improve their ability to fight tumors before returning them to the patients’ bodies.

Continue reading

Scientists Discover Immune Cell That Kills Most Cancers

By Kristin Houser – Re-Blogged From Futurism

“Previously nobody believed this could be possible.”

A newly discovered immune cell could lead to the creation of a universal cancer treatment — a “Holy Grail” treatment that would work for all cancers, in all people.

The treatment leverages T-cells, a type of white blood cell that helps our bodies’ immune systems by scanning for and killing abnormal cells. For background, scientists have recently started harnessing that ability in the fight against cancer through a therapy called CAR-T, which involves removing T-cells from a patient’s blood and genetically engineering them to seek out and destroy cancer cells.

Continue reading

Engineer Finds Way to Pull Diseases From Blood Using Magnets

By Kristin Houser – Re-Blogged From Futurism
“In theory, you can go after almost anything. Poisons, pathogens, viruses, bacteria…”

A British engineer has found a way to filter unwanted cells from blood using magnets — and his tool could be used in clinical trials as soon as next year.

Thanks to existing research, biochemical scientist George Frodsham knew it was possible to force magnetic nanoparticles to bind to specific cells in the body. But while other researchers did so primarily to make those cells show up in images, he wondered whether the same technique might allow doctors to remove unwanted cells from the blood.

Continue reading

Fraud and Corruption Bring Big Payoffs

California judges provide stage for kangaroo court justice over Roundup weedkiller

By Paul Driessen – Re-Blogged From WUWT

San Francisco area juries have awarded cancer patients some $80 million each, based on claims that the active ingredient in Roundup weedkiller, caused their cancer – and that Bayer-Monsanto negligently or deliberately failed to warn consumers that the glyphosate it manufactures is carcinogenic. (It’s not.) Judges reduced the original truly outrageous awards of $289 million and even $1 billion per plaintiff!

Meanwhile, ubiquitous ads are still trolling for new clients, saying anyone who ever used Roundup and now has Non-Hodgkin Lymphoma or other cancer could be the next jackpot justice winner. Mass tort plaintiff law firms have lined up 18,500 additional “corporate victims” for glyphosate litigation alone.

Continue reading

A Personal Note.

By Bob Shapiro

Many of you know that I am living through Prostate Cancer. The treatments seem to be focused on using a couple of weeks here, or a couple of weeks there in an effort to add several months down the road.

I’ve had a good life- not that I’m rushing to say good-bye at 73 – and it’s been interesting to see how my priorities have been brought more clearly into focus.

I’ve been very happy sharing my ideas these last 5 years (whether I’ve written them or someone else) on my Blog and on Facebook. If you’ve found them worth your time enough to read some of them, well thank you.

Continue reading

Advance in Slowing Prostate Cancer Made in Clinical Trials

By Health Day – Re-Blogged From Newsmax Health

Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.

Two drugs that interfere with cancer’s ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that do not respond to regular therapy.

But these trials show the drugs also can improve survival and slow progression in prostate cancers that do respond to regular therapy, which typically involves medication that halts production of testosterone.

Study Proves Drug Cuts Prostate Cancer Risk

By Health Day – Re-Blogged From Newsmax Helth

Finasteride, best known as the enlarged-prostate medicine Proscar, is a safe, effective way to reduce the risk of prostate cancer, according to long-term findings from the Prostate Cancer Prevention Trial (PCPT).

The trial was funded by the U.S. National Cancer Institute and enrolled nearly 19,000 men between 1993 and 1997. Initially it found that finasteride — a hormone-blocking drug — cut the risk of prostate cancer by 25 percent. Those results were published in 2003.

The newly released long-term data show that the reduction of prostate cancer risk has continued and that fewer than 100 men in the trial died from prostate cancer in more than two decades of follow-up, according to a research team led by Dr. Ian Thompson.